Yoshimitsu Kobayashi

Randomized Controlled Trial on the Skin Toxicity of Panitumumab in Japanese Patients with Metastatic Colorectal Cancer: HGCSG1001 Study; J-STEPP

Yoshimitsu Kobayashi, Yoshito Komatsu, Satoshi Yuki et al. · Future Oncology · 2015 · 85 citations

Medicine, Oncology, Pharmacology +15

Phase II study of combined chemotherapy with irinotecan and S-1 (IRIS) plus bevacizumab in patients with inoperable recurrent or advanced colorectal cancer

Yoshito Komatsu, Satoshi Yuki, Susumu Sogabe et al. · Acta Oncologica · 2012 · 19 citations · Full text

Medicine, Oncology, Pharmacology +13

Mononuclear tetracarbonylrhodate Rh(CO)₄^–. A new aspect of syngas conversion into ethylene glycol

Eiichi Watanabe, Kenji Murayama, Yoshinori Hara et al. · Journal of the Chemical Society Chemical Communications · 1986 · 16 citations

Natural Sciences, Chemistry, Catalysis +9

Interferon-free therapy with sofosbuvir plus ribavirin for successful treatment of genotype 2 hepatitis C virus with lichen planus: a case report

Ayumu Yoshikawa, Katsumi Terashita, Kenichi Morikawa et al. · Clinical Journal of Gastroenterology · 2017 · 15 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Reverce: Randomized phase II study of regorafenib followed by cetuximab versus the reverse sequence for metastatic colorectal cancer patients previously treated with fluoropyrimidine, oxaliplatin, and irinotecan.

Kohei Shitara, Takeharu Yamanaka, Tadamichi Denda et al. · Journal of Clinical Oncology · 2018 · 15 citations

Medicine, Oncology, Pharmacology +14